Correcting a mutation in a patient with a debilitating disease used to seem like science fiction, but the advent of CRISPR editing made this dream a reality. In this webinar, experts will review recent advances in and applications of CRISPR for drug screening and correcting mutations in diseased patients.
Topics to be covered
Speaker
Mazhar Adli, PhD
Associate Professor, Department of Obstetrics and Gynecology
Robert H. Lurie Comprehensive Cancer Center
Feinberg School of Medicine at Northwestern University
William Dampier, PhD
Assistant Professor
Department of Microbiology and Immunology
Drexel University College of Medicine
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy